SRHU Jolly Grant and BCIL Sign MoU

Published on: May 24, 2024

Swami Rama Himalayan University Jolly Grant and BCIL Sign MoU

Both Institutions to Collaborate in Innovation and Technology Transfer

Swami Rama Himalayan University Jolly Grant and Biotech Consortium India Limited (BCIL) New Delhi will now collaborate in the field of innovation and technology transfer. An MoU was signed between the two institutions to this effect.

Under the guidance of Dr. Vijay Dhasmana, President of Swami Rama Himalayan University (SRHU), the MoU was signed by Registrar Dr. Mukesh Bijlwan and Dr. Purnima Sharma, Managing Director of BCIL.

On this occasion, SRHU Vice Chancellor Dr. Rajendra Dobhal said that this MoU will accelerate the development of a culture of innovation and entrepreneurship amongst faculty and students. Both parties will work together on technology evaluation, licensing agreements, IP management, and quality assurance measures.

Dr. Dobhal emphasized the university’s commitment to promoting a favorable environment for technology transfer and its commercialization. He mentioned that this collaboration would help in fostering socio-economic development and creating new pathways for research and innovation.

Dr. Purnima Sharma, Managing Director of BCIL, highlighted the importance of strong IP management and public-private partnerships in advancing innovation and economic development. She stated that SRHU, known for its commitment to research excellence and technology development, is sure to play a crucial role in providing the necessary technical expertise and knowledge for the successful transfer of technologies.

WhatsApp-Image-2024-05-22-at-5.32.38-PM.jpeg
   Admissions Form         

Admission Open For 2025

×
International Endowed Chair Professor

Prof Rakesh Kumar

Prof Rakesh Kumar is the Founder and President of the Breast Cancer in Young Women Foundation (USA), dedicated to vaddressing the distinct issues affecting young women with breast cancer. He also serves as the International Endowed Chair Professor at the Cancer Research Institute of the Himalayan Institute of Medical Sciences. Additionally, he holds adjunct professorships at Rutgers New Jersey Medical School and Virginia Commonwealth University.

Dr Kumar earned his Ph.D. from the All India Institute of Medical Sciences in 1984 and began his research career at Memorial Sloan Kettering Cancer Center in January 1986. From 1988 to 2017, he held various academic and leadership positions —including faculty member, tenured professor, distinguished professor, endowed chair, department chair, and research leader—at esteemed institutions such as Memorial Sloan Kettering Cancer Center in New York and the University of Texas MD Anderson Cancer Center in Houston. From 2017 to 2022, he served as the National Chair for Cancer Research for the Government of India and as a distinguished professor, continuing his innovative work in breast cancer research.

With nearly 40 years of research and professional experience, Dr. Kumar has made conceptual contributions to the field of cancer research (h-index 108, citations >50,000). He has authored over 325 peer-reviewed publications, edited or co-edited nine books, and delivered 290 invited lectures worldwide. His work has been featured on the covers of 18 major cancer journals and has been highlighted in institutional research reports of the MD Anderson Cancer Center.

A passionate educator and mentor, Dr. Kumar has guided 67 trainees throughout his career. He serves on the editorial boards of multiple leading cancer journals and has served on the editorial boards of 21 top cancer journals. His global reputation is further demonstrated by his participation in about 100 peer-review panels for cancer research funding in the US and internationally over the past 28 years.

Dr. Kumar's innovative research has earned him numerous prestigious honors, including the Hinkle Society Faculty Award at Penn State University (1994), the Dalla/Fort Worth Living Legend Faculty Achievement Award in Basic Sciences (2004), the Ranbaxy Research Award (2006), and the Lifetime Achievement Award from the American Association of Indian Scientists in Cancer Research (2013), among others. Dr. Kumar's pioneering research continues to have a profound influence on the fields of oncology and breast cancer, opening up new opportunities for biomedical scientists and trainees worldwide.